Three pharma stocks that should be on your radar today
While drugmakers like Dr. Reddy's Laboratories and Aurobindo Pharma are in focus on the back of the observations issued by the USFDA, Biocon may react to a settlement agreement for a key drug.
While drugmakers like Dr. Reddy's Laboratories and Aurobindo Pharma are in focus on the back of the observations issued by the USFDA, Biocon may react to a settlement agreement for a key drug.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
